Skip to main content

ProPhase Labs, Inc.

PRPH
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0000868278

No open-market purchases or sales by ProPhase Labs, Inc. insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $2 in total; no superinvestor holds it.

Superinvestors holding PRPH, Q2 2026

See all superinvestors

No superinvestor reported holding PRPH in Q2 2026.